“Today, lymphoma is no longer the only disease linked to EBV (Epstein-Barr virus). A growing body of evidence suggests the virus may also be a necessary precondition for the development of multiple sclerosis. And EBV is hardly the only virus that leaves a permanent mark.”
"Unless we act to prevent the dismantling of our vaccine system, people who could be spared the long-term consequences of viral disease will lose out on that possibility."
The latest from @scottgottliebmd.bsky.social: https://wapo.st/3Zmu7pE
My segment today on CBS ‘Face the Nation’ on the measles epidemic, anti-vaccine policies, and the growing risk from once vanquished infectious diseases.
Former @fda.gov Commissioner Dr. @scottgottliebmd.bsky.social, who sits on the boards of Pfizer and UnitedHealthcare, told @facethenation.bsky.social that the current measles outbreak could be a "long cycle, especially now that this has gotten embedded in political psyche in this country."
My essay in the Sunday Washington Post: “A viral infection can have devastating effects. I experienced this firsthand.” @washingtonpost.com
wapo.st/3MhEY0U
Gift 🎁 link, b/c this is a really great, straightforward op-ed by Scott Gottlieb, who was FDA Commissioner during Trump's first term. Gottlieb developed Hodgkin lymphoma from Epstein-Barr virus (EBV).
Key excerpts & commentary ⬇️, in case you can't read the whole thing.
🧵1/13
wapo.st/4a3ofYv
My Op Ed in Today's Washington Post: "The long-lasting effects of viruses — and the anti-vaccine movement. For some people, a viral infection can have devastating long-term effects."
wapo.st/4qjFtWk
The latest from @scottgottliebmd.bsky.social:
It's a good and personal piece. Earlier in his adult life, Gottlieb had Hodgkins disease, almost certainly as a result of Epstein-Barr virus infection. (Happily, Hodgkins is usually quite treatable cancer, as it was for him.)
The long-lasting effects of viruses — and the anti-vaccine movement: Dr. @scottgottliebmd.bsky.social had cancer caused by EBV, and remind us that viruses can leave life-long harms and risks, and vaccines that prevent infections prevent those, too. @postopinions.bsky.social wapo.st/4qjFtWk
My Op Ed in Today's Washington Post: "The long-lasting effects of viruses — and the anti-vaccine movement. For some people, a viral infection can have devastating long-term effects."
wapo.st/4qjFtWk
From an earlier post…
bsky.app/profile/scot...
Predictably, anti-vaccine groups are leveraging HHS action to move most pediatric vaccines off the recommended schedule (and conform U.S. guidelines to Denmark) to pressure red state legislatures to eliminate vaccinations as part of school entrance requirements.
www.statnews.com/2026/01/29/v...
It appears that the new dietary guidelines stopped short of strengthening the recommendation to reduce alcohol consumption and may have weakened it — a missed public health opportunity that should be revisited as these guidelines are refined and updated.
www.nbcnews.com/news/amp/rcn...
This is a policy choice. As Dr. Gottlieb recently put the issue on CNBC: if we substantially reduce vaccination rates, "we're going to have to build new pediatric hospitals." www.youtube.com/watch?v=e8CJ...
Shifting many pediatric vaccines into the category of shared clinical decision-making means in many red states governors and legislators will be pressured to strip them from school-entry requirements. Vaccination rates could fall sharply with stark regional differences in protection against disease
Shifting many pediatric vaccines into the category of shared clinical decision-making means in many red states governors and legislators will be pressured to strip them from school-entry requirements. Vaccination rates could fall sharply with stark regional differences in protection against disease
My segment on CNBC today
Gottlieb: ‘If We Go to the Danish Model and We Substantially Reduce Vaccination … We’re Going to Have to Build New Pediatric Hospitals’
grabien.com/story?id=562...
To foster disruptive innovation with the potential to change medical paradigms, NIH policies should channel more funding to unconventional ideas and the early-career investigators who are pursuing them, a theme that I take up in my forthcoming book, Miracle Century
www.statnews.com/2025/12/18/n...
To foster disruptive innovation with the potential to change medical paradigms, NIH policies should channel more funding to unconventional ideas and the early-career investigators who are pursuing them, a theme that I take up in my forthcoming book, Miracle Century
www.statnews.com/2025/12/18/n...
NBC News: ‘Whooping cough cases soar as vaccination rates drop: In an NBC News data investigation of 31 states, about 70% of counties and jurisdictions fell below the target vaccination rate needed for community protection.’
www.nbcnews.com/health/kids-...
Must-read for health care regulators, by former FDA head @scottgottliebmd.bsky.social, pointing out challenges of introducing AI in health care systems -> Approval, benefit assessment and reimbursement regulation need system-specific consideration and design in order to support productivity gains!
12 former commissioners of the FDA came together to write a Perspectives piece for the New England Journal of Medicine; raising our concerns about recent changes to vaccine approval policy at the FDA and its implications for patients and public health.
My article in the current issue of JAMA Health Forum: “How AI Will Help Solve Medicine’s Productivity Challenges.”
My segment on Face the Nation today on recent changes by CDC’s vaccine advisory committee to the pediatric schedule.
www.cbsnews.com/video/scott-...
Dr. Gottlieb: FDA is systemically trying to dismantle components of the vaccine approval process cnb.cx/4pfHbrT with @scottgottliebmd.bsky.social @cnbc.com
If new proposals detailed in an FDA memo are put into place, experts told me it would mean the end of annual flu shots. And end of most vaccines for pregnant people. And maybe the end of updates to pneumonia vaccines. And more.
www.cidrap.umn.edu/childhood-va...
12 former commissioners of the FDA came together to write a Perspectives piece for the New England Journal of Medicine; raising our concerns about recent changes to vaccine approval policy at the FDA and its implications for patients and public health.